Stock comparison
Medline Inc. is 31.5x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($49.12 B vs $1.56 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 31.5x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($49.12 B vs $1.56 B).
Market value leader
MDLN
Medline Inc. is 31.5x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($49.12 B vs $1.56 B).
Revenue leader
MDLN
KMTS: $59.81M vs MDLN: $28.43B.
Profit leader
MDLN
KMTS: -$113.81M vs MDLN: $1.16T.
Margin leader
MDLN
KMTS: -190.3% vs MDLN: 4069.4% net margin.
| Metric | KMTS | MDLN |
|---|---|---|
| Market cap | $1.56 B | $49.12 B |
| US-listed rank | #2334 | #328 |
| Revenue (latest FY) | $59.81M | $28.43B |
| Net income (latest FY) | -$113.81M | $1.16T |
| Net margin | -190.3% | 4069.4% |
| P/E (trailing FY) | - | 0.0x |
| SEC filings | 105 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 31.5x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($49.12 B vs $1.56 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while Medline Inc. reported $28.43B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and Medline Inc., or browse the full rankings.